导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.96% | 3996/4773 |
| 近一周 | -2.05% | 3314/5465 |
| 近一月 | -0.62% | 909/5421 |
| 近一季 | -8.76% | 3401/5231 |
| 近半年 | -17.98% | 4277/4920 |
| 近一年 | -0.66% | 2872/4394 |
| 近两年 | 33.63% | 2146/2954 |
| 近三年 | -2.54% | 1965/2253 |
| 成立以来 | 15.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.37% 2262/4961 |
-1.54% 3354/5312 |
- - |
- - |
| 2025 | 23.66% 1854/4813 |
-1.15% 2593/3635 |
10.28% 256/4076 |
6.79% 3511/4524 |
6.23% 370/4813 |
| 2024 | 0.31% 2081/3463 |
-12.70% 2463/2808 |
1.42% 474/3014 |
12.32% 2375/3129 |
0.86% 1157/3463 |
| 2023 | -21.88% 1914/2656 |
-7.89% 2178/2280 |
0.60% 303/2385 |
-9.43% 1822/2515 |
-6.93% 1984/2655 |
| 2022 | -25.36% 1313/2207 |
-24.47% 1766/1919 |
8.84% 323/2016 |
-6.16% 96/2113 |
-3.26% 1844/2208 |
| 2021 | 18.97% 199/1822 |
-21.32% 1212/1255 |
12.68% 321/1330 |
10.53% 120/1466 |
21.41% 23/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 鹏华空天军工指数(LOF)C VS. 长安沪深300非周期A(740101) |